Last reviewed · How we verify
NCT04764435
The Effect of Physician Ownership on Dialysis Outcomes
trial testing Physician ownership in Renal Dialysis in 208,213 participants. Completed in 31 December 2017.
31 December 2017
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 208,213 |
| Start date | 1 January 2017 |
| Primary completion | 31 December 2017 |
| Estimated completion | 31 December 2017 |
Drugs / interventions tested
- Physician ownership
- Large dialysis organization ownership
Conditions studied
- Renal Dialysis — all drugs for Renal Dialysis →
- Financial Disclosure — all drugs for Financial Disclosure →
Sponsor
University of Southern California
Who can join
18 and older, any sex, with Renal Dialysis or Financial Disclosure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many dialysis facilities have financial relationships with nephrologists, including joint venture agreements, where the nephrologist owns a minority share of the dialysis facility. Such agreements could present a conflict of interest with respect to patient care. This study will investigate whether these joint venture agreements are associated with differences in the quality of care provided by dialysis facilities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04764435
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Renal Dialysis
Currently open trials in the same condition.
- NCT06742827 — Educational Intervention and Adherence · NA · active not recruiting
- NCT06568835 — The Effect of Active Exercise on Maintenance Haemodialysis Patients · NA · recruiting
- NCT06584734 — Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients · NA · active not recruiting
- NCT05755503 — Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients · recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04764435 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 16 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04764435.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing